186 related articles for article (PubMed ID: 1695324)
1. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
[TBL] [Abstract][Full Text] [Related]
2. Molecular and biochemical characterization of the human trk proto-oncogene.
Martin-Zanca D; Oskam R; Mitra G; Copeland T; Barbacid M
Mol Cell Biol; 1989 Jan; 9(1):24-33. PubMed ID: 2927393
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
Albor A; Thraves PJ; Dritschilo A; Notario V
Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
Mitra G
Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
[TBL] [Abstract][Full Text] [Related]
5. The trk family of oncogenes and neurotrophin receptors.
Lamballe F; Klein R; Barbacid M
Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
[TBL] [Abstract][Full Text] [Related]
6. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
[TBL] [Abstract][Full Text] [Related]
7. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
[TBL] [Abstract][Full Text] [Related]
8. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
[TBL] [Abstract][Full Text] [Related]
9. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
Kozma SC; Redmond SM; Fu XC; Saurer SM; Groner B; Hynes NE
EMBO J; 1988 Jan; 7(1):147-54. PubMed ID: 2966065
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of activation of the human trk oncogene.
Coulier F; Martin-Zanca D; Ernst M; Barbacid M
Mol Cell Biol; 1989 Jan; 9(1):15-23. PubMed ID: 2538716
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
[TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
Mitra G; Martin-Zanca D; Barbacid M
Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.
Rodrigues GA; Naujokas MA; Park M
Mol Cell Biol; 1991 Jun; 11(6):2962-70. PubMed ID: 1710022
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract][Full Text] [Related]
15. Human TRK proto-oncogene maps to chromosome 1q32-q41.
Miozzo M; Pierotti MA; Sozzi G; Radice P; Bongarzone I; Spurr NK; Della Porta G
Oncogene; 1990 Sep; 5(9):1411-4. PubMed ID: 2216464
[TBL] [Abstract][Full Text] [Related]
16. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.
O'Brien MC; Fukui Y; Hanafusa H
Mol Cell Biol; 1990 Jun; 10(6):2855-62. PubMed ID: 2111444
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the activating mutations in v-erbB of avian erythroblastosis virus strain R.
Shu HK; Pelley RJ; Kung HJ
J Virol; 1991 Nov; 65(11):6173-80. PubMed ID: 1681117
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.
Shu HK; Pelley RJ; Kung HJ
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9103-7. PubMed ID: 1979168
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of activation of the vav protooncogene.
Coppola J; Bryant S; Koda T; Conway D; Barbacid M
Cell Growth Differ; 1991 Feb; 2(2):95-105. PubMed ID: 2069873
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
Eager KB
Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
